import InfoAlert from "../elements/InfoAlert";
import AlertItem from "../elements/AlertItem";

const References = () => {
  return (
    <div className="col-12">
      <InfoAlert title="References :" isToggled>
        <AlertItem>
          Mesraoua B, Deleu D, Kullmann DM, et al. Novel therapies for epilepsy
          in the pipeline. Epilepsy Behav. 2019 Aug;97:282-290.
        </AlertItem>
        <AlertItem>
          <a href="https://www.genecards.org/" rel="noreferrer" target="_blank">
            https://www.genecards.org/accessed on 23 February 2022.
          </a>
        </AlertItem>
        <AlertItem>
          <a
            href="https://medlineplus.gov/genetics/"
            rel="noreferrer"
            target="_blank"
          >
            https://medlineplus.gov/genetics/accessed on 24 February 2022.
          </a>
        </AlertItem>

        <AlertItem>
          Bayat A, Bayat M, Rubboli G, Møller RS. Epilepsy Syndromes in the
          First Year of Life and Usefulness of Genetic Testing for Precision
          Therapy. Genes (Basel). 2021 Jul 8;12(7):1051.
        </AlertItem>
        <AlertItem>
          Brunklaus A, Lal D. Sodium channel epilepsies and neurodevelopmental
          disorders: from disease mechanisms to clinical application. Dev Med
          Child Neurol. 2020 Jul;62(7):784-792.
        </AlertItem>
        <AlertItem>
          Helbig I, Ellis CA. Personalized medicine in genetic epilepsies -
          possibilities, challenges, and new frontiers. Neuropharmacology. 2020
          Aug 1;172:107970.
        </AlertItem>
        <AlertItem>
          Guerrini R, Balestrini S, Wirrell EC, Walker MC. Monogenic Epilepsies:
          Disease Mechanisms, Clinical Phenotypes, and Targeted Therapies.
          Neurology. 2021 Oct 26;97(17):817-831.
        </AlertItem>
        <AlertItem>
          Klepper J, Akman C, Armeno M, et al. Glut1 Deficiency Syndrome
          (Glut1DS): State of the art in 2020 and recommendations of the
          international Glut1DS study group. Epilepsia Open. 2020 Aug
          13;5(3):354-365.
        </AlertItem>
        <AlertItem>
          Marini C, Giardino M. Novel treatments in epilepsy guided by genetic
          diagnosis. Br J Clin Pharmacol. 2021 Nov 15. doi: 10.1111/bcp.15139.
          Epub ahead of print. PMID: 34778987.
        </AlertItem>
        <AlertItem>
          Moloney PB, Cavalleri GL, Delanty N. Epilepsy in the mTORopathies:
          opportunities for precision medicine. Brain Commun. 2021 Sep
          25;3(4):fcab222.
        </AlertItem>
        <AlertItem>
          Morrison-Levy N, Borlot F, Jain P, Whitney R. Early-Onset
          Developmental and Epileptic Encephalopathies of Infancy: An Overview
          of the Genetic Basis and Clinical Features. Pediatr Neurol. 2021
          Mar;116:85-94.
        </AlertItem>
        <AlertItem>
          Overwater IE, Rietman AB, van Eeghen AM, de Wit MCY. Everolimus for
          the treatment of refractory seizures associated with tuberous
          sclerosis complex (TSC): current perspectives. Ther Clin Risk Manag.
          2019 Jul 26;15:951-955.
        </AlertItem>
        <AlertItem>
          Sharma P, Hussain A, Greenwood R. Precision in pediatric epilepsy.
          F1000Res. 2019 Feb 6;8:F1000 Faculty Rev-163. doi:
          10.12688/f1000research.16494.1.
        </AlertItem>
        <AlertItem>
          Specchio N, Pietrafusa N, Perucca E, Cross JH. New paradigms for the
          treatment of pediatric monogenic epilepsies: Progressing toward
          precision medicine. Epilepsy Behav. 2021 Apr 15:107961.
        </AlertItem>
        <AlertItem>
          Striano P, Minassian BA. From Genetic Testing to Precision Medicine in
          Epilepsy. Neurotherapeutics. 2020 Apr;17(2):609-615.
        </AlertItem>
        <AlertItem>
          Swanson LC, Ahmed R. Epilepsy Syndromes: Current Classifications and
          Future Directions. Neurosurg Clin N Am. 2022 Jan;33(1):113-134.
        </AlertItem>
        <AlertItem>
          Specchio N, Ferretti A, Trivisano M, et al. Neuronal Ceroid
          Lipofuscinosis: Potential for Targeted Therapy. Drugs. 2021
          Jan;81(1):101-123.
        </AlertItem>
        <AlertItem>
          Nitschke F, Ahonen SJ, Nitschke S, Mitra S, Minassian BA. Lafora
          disease - from pathogenesis to treatment strategies. Nat Rev Neurol.
          2018 Oct;14(10):606-617.
        </AlertItem>
        <AlertItem>
          Barcia G, Rio M, Assouline Z, et al. Novel FARS2 variants in patients
          with early onset encephalopathy with or without epilepsy associated
          with long survival. Eur J Hum Genet. 2021 Mar;29(3):533-538.
        </AlertItem>
        <AlertItem>
          Lin Z, Sang T, Yang Y, et al. Efficacy of Anti-seizure Medications,
          Quinidine, and Ketogenic Diet Therapy for KCNT1-Related Epilepsy and
          Genotype-Efficacy Correlation Analysis. Front Neurol. 2022 Jan
          18;12:834971.
        </AlertItem>
        <AlertItem>
          D'Gama AM, Poduri A. Precision Therapy for Epilepsy Related to Brain
          Malformations. Neurotherapeutics. 2021 Jul;18(3):1548-1563.
        </AlertItem>
        <AlertItem>
          Sun Y, Wan L, Yan H, Li Z, Yang G. Phenotypic and Genotypic
          Characterization of NPRL2-Related Epilepsy: Two Case Reports and
          Literature Review. Front Neurol. 2021 Nov 29;12:780799.
        </AlertItem>
        <AlertItem>
          Canavati C, Klein KM, Afawi Z, et al. Inclusion of hemimegalencephaly
          into the phenotypic spectrum of NPRL3 pathogenic variants in familial
          focal epilepsy with variable foci. Epilepsia. 2019 Jun;60(6):e67-e73.
        </AlertItem>
        <AlertItem>
          Dell'Isola GB, Vinti V, Fattorusso A, et al. The Broad Clinical
          Spectrum of Epilepsies Associated With Protocadherin 19 Gene Mutation.
          Front Neurol. 2022 Jan 17;12:780053.
        </AlertItem>
        <AlertItem>
          Zhao Q, Hu Y, Liu Z, et al. PRRT2 variants and effectiveness of
          various antiepileptic drugs in self-limited familial infantile
          epilepsy. Seizure. 2021 Oct;91:360-368.
        </AlertItem>
        <AlertItem>
          Goodspeed K, Pérez-Palma E, Iqbal S, et al. Current knowledge of
          SLC6A1-related neurodevelopmental disorders. Brain Commun. 2020 Oct
          13;2(2):fcaa170.
        </AlertItem>
        <AlertItem>
          Xian J, Parthasarathy S, Ruggiero SM, et al. Assessing the landscape
          of STXBP1-related disorders in 534 individuals. Brain. 2021 Nov
          23:awab327.
        </AlertItem>
      </InfoAlert>
    </div>
  );
};

export default References;
